-
[1]
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang, Hui Xiao, 2015: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines, Virologica Sinica, 30, 174-189. doi: 10.1007/s12250-015-3606-3
-
[2]
Kaissar Tabynov, Zhailaubai Kydyrbayev, Abylai Sansyzbay, Berik Khairullin, Sholpan Ryskeldinova, Nurika Assanzhanova, Yerken Kozhamkulov, Dulat Inkarbekov, 2012: Immunogenic and Protective Properties of the First Kazakhstan Vaccine against Pandemic Influenza A(H1N1) pdm09 in Ferrets, Virologica Sinica, 27, 345-352. doi: 10.1007/s12250-012-3272-7
-
[3]
Wei-wei Gai, Yan Zhang, Di-han Zhou, Yao-qing Chen, Jing-yi Yang, Hui-min Yan, 2011: PIKA Provides an Adjuvant Effect to Induce Strong Mucosal and Systemic Humoral Immunity Against SARS-CoV*, Virologica Sinica, 26, 81-94. doi: 10.1007/s12250-011-3183-z
-
[4]
Jianchun Wei, Hui Chen, Jing An, 2014: Recent progress in dengue vaccine development, Virologica Sinica, 29, 353-363. doi: 10.1007/s12250-014-3542-7
-
[5]
肖春惠, 杨占秋, 2001: The Development of The Hantan Virus Vaccine, Virologica Sinica, 16, 299-303.
-
[6]
Lianxing Liu, Chao Qiu, Yang Huang, Jianqing Xu, Yiming Shao, 2013: Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine, Virologica Sinica, 28, 109-115. doi: 10.1007/s12250-013-3303-z
-
[7]
Karen A O Martins, Travis K Warren, Sina Bavari, 2013: Characterization of a Putative Filovirus Vaccine: Virus-Like Particles, Virologica Sinica, 28, 65-70. doi: 10.1007/s12250-013-3306-9
-
[8]
Ling Tao, JianJun Chen, Jin Meng, Yao Chen, Hongxia Li, Yan Liu, Zhenhua Zheng, Hanzhong Wang, 2013: Enhanced Protective Efficacy of H5 Subtype Influenza Vaccine with Modification of the Multibasic Cleavage Site of Hemagglutinin in Retroviral Pseudotypes, Virologica Sinica, 28, 136-145. doi: 10.1007/s12250-013-3326-5
-
[9]
Jun-jun Shao, Jing-feng Wang, Hui-yun Chang, Ji-xing Liu, 2011: Immune Potential of a Novel Multiple-epitope Vaccine to FMDV Type Asia 1 in Guinea Pigs and Sheep, Virologica Sinica, 26, 190-197. doi: 10.1007/s12250-011-3174-0
-
[10]
Huawei Mao, Hui-Ling Yen, Yinping Liu, Yu-Lung Lau, J.S. Malik Peiris, Wenwei Tu, 2014: Conservation of T cell epitopes between seasonal influenza viruses and the novel influenza A H7N9 virus, Virologica Sinica, 29, 170-175. doi: 10.1007/s12250-014-3473-3
-
[11]
Ning Luan, Han Cao, Yunfei Wang, Kangyang Lin, Cunbao Liu, 2022: LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with ShingrixTM in VZV-primed mice, Virologica Sinica, 37, 731-739. doi: 10.1016/j.virs.2022.06.002
-
[12]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
-
[13]
Jinliang Liu, Shiyu Dai, Manli Wang, Zhihong Hu, Hualin Wang, Fei Deng, 2016: Virus like particle-based vaccines against emerging infectious disease viruses, Virologica Sinica, 31, 279-287. doi: 10.1007/s12250-016-3756-y
-
[14]
Yi ZENG, 2007: Strategy for AIDS Prevention and Treatment, Virologica Sinica, 22, 419-420.
-
[15]
Peng Zhou, Zhenggang Han, Lin-Fa Wang, Zhengli Shi, 2013: Identification of Immunogenic Determinants of the Spike Protein of SARS-like Coronavirus, Virologica Sinica, 28, 92-96. doi: 10.1007/s12250-013-3292-y
-
[16]
Zhiwei Wu, Qingliang Li, Yan Liu, Huakun Lv, Zhaojun Mo, Fangjun Li, Qingchuan Yu, Fei Jin, Wei Chen, Yong Zhang, Teng Huang, Xiaosong Hu, Wei Xia, Jiamei Gao, Haisong Zhou, Xuan Bai, Yueyue Liu, Zhenzhen Liang, Zhijun Jiang, Yingping Chen, Jiuwei Zhang, Jialiang Du, Biao Yang, Bo Xing, Yantao Xing, Ben Dong, Qinghai Yang, Chen Shi, Tingdong Yan, Bo Ruan, Haiyun Shi, Xingliang Fan, Dongyang Feng, Weigang Lv, Dong Zhang, Xiangchu Kong, Liuyifan Zhou, Dinghong Que, Hong Chen, Zhongbing Chen, Xiang Guo, Weiwei Zhou, Cong Wu, Qingrong Zhou, Yuqing Liu, Jian Qiao, Ying Wang, Xinguo Li, Kai Duan, Yuliang Zhao, Gelin Xu, Xiaoming Yang, 2022: Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants, Virologica Sinica, 37, 724-730. doi: 10.1016/j.virs.2022.07.011
-
[17]
Xiaoqiang Hao, Yilong Wang, Mengying Zhu, Dongming Zhou, Rongxian Liu, Bin Wang, Yao-Wei Huang, Zhengyan Zhao, 2021: Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein, Virologica Sinica, 36, 521-536. doi: 10.1007/s12250-020-00326-y
-
[18]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
-
[19]
Hewei Zhang, Mingqi Xia, Wei Wang, Decai Ju, Long Cao, Bai Wu, Xin Wang, Ying Wu, Ni Song, Jiaxin Hu, Changxiao Tian, Shucheng Zhang, Hua Wu, 2018: An Attenuated Highly Pathogenic Chinese PRRS Viral Vaccine Confers Cross Protection to Pigs against Challenge with the Emerging PRRSV NADC30-Like Strain, Virologica Sinica, 33, 153-161. doi: 10.1007/s12250-018-0027-0
-
[20]
卢曾军, 曹轶梅, 刘在新*, 谢庆阁, 2006: Advance of Adenoviral Vector in Gene Therapy and Vaccine Research, Virologica Sinica, 21, 622-626.